Bornea, Baby Boy .

HRN: 21-94-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/19/2022
09/26/2022
IV
48mg
Q24h
Neonatal Depression, R/o Hie
Waiting Final Action 

 Indication:  Prophylaxis    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes